ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $43,000 | +87.0% | 25,258 | +33.6% | 0.00% | – |
| Q4 2020 | $23,000 | -39.5% | 18,906 | +13.5% | 0.00% | – |
| Q4 2018 | $38,000 | -24.0% | 16,663 | +28.3% | 0.00% | – |
| Q3 2018 | $50,000 | +16.3% | 12,984 | +0.9% | 0.00% | – |
| Q2 2018 | $43,000 | -63.9% | 12,865 | -66.0% | 0.00% | – |
| Q1 2017 | $119,000 | +36.8% | 37,802 | +13.3% | 0.00% | – |
| Q4 2016 | $87,000 | -28.7% | 33,359 | +6.0% | 0.00% | – |
| Q3 2016 | $122,000 | +43.5% | 31,468 | -0.8% | 0.00% | – |
| Q2 2016 | $85,000 | -95.5% | 31,707 | -82.8% | 0.00% | -100.0% |
| Q2 2014 | $1,887,000 | -52.7% | 184,137 | -44.5% | 0.00% | -50.0% |
| Q1 2014 | $3,986,000 | +55.2% | 331,892 | +46.1% | 0.00% | +100.0% |
| Q4 2013 | $2,569,000 | – | 227,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |